In this blog, we reported earlier about a new nullity action initiated in 2010 against the German supplementary protection certificate (SPC) for enantiomeric escitalopram and the judgment of the…
After the Federal Court of Justice (Bundesgerichtshof, BGH) had confirmed the validity of the German SPC for the enantiomeric escitalopram (and its underlying patent) in 2009, the Federal Patent…
One of the new question marks introduced by Directive 2004/48 (the so-called "Enforcement Directive") is what amount of indicia is required to prove that an act of infringement is "imminent" for the…
